Literature DB >> 28697849

Post market surveillance in the german medical device sector - current state and future perspectives.

Claus Zippel1, Sabine Bohnet-Joschko2.   

Abstract

Medical devices play a central role in the diagnosis and treatment of diseases but also bring the potential for adverse events, hazards or malfunction with serious consequences for patients and users. Medical device manufacturers are therefore required by law to monitor the performance of medical devices that have been approved by the competent authorities (post market surveillance). Conducting a nationwide online-survey in the German medical device sector in Q2/2014 in order to explore the current status of the use of post market instruments we obtained a total of 118 complete data sets, for a return rate of 36%. The survey included manufacturers of different sizes, producing medical devices of all risk classes. The post market instruments most frequently reported covered the fields of production monitoring and quality management as well as literature observation, regulatory vigilance systems, customer knowledge management and market observation while Post Market Clinical Follow-up and health services research were being used less for product monitoring. We found significant differences between the different risk classes of medical devices produced and the intensity of use of post market instruments. Differences between company size and the intensity of instruments used were hardly detected. Results may well contribute to the development of device monitoring which is a crucial element of the policy and regulatory system to identify device-related safety issues.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  European Union; In vitro diagnostic regulations (IVDR); Medical device regulation (MDR); Medical devices; Post marketing; Product surveillance

Mesh:

Year:  2017        PMID: 28697849     DOI: 10.1016/j.healthpol.2017.06.005

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  3 in total

1.  Analysis of Allergan's Biocell Implant Recall in a Major University Breast Center.

Authors:  Michel A Danino; Lan Dao; Meir Retchkiman; Edwige Matetsa; Jessica Iezzoni; Joseph S Bou-Merhi
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-06-25

2.  Do Regulatory Changes Seriously Affect the Medical Devices Industry? Evidence From the Czech Republic.

Authors:  Petra Maresova; Lukas Rezny; Lukas Peter; Ladislav Hajek; Frank Lefley
Journal:  Front Public Health       Date:  2021-04-28

3.  Rise of Clinical Studies in the Field of Machine Learning: A Review of Data Registered in ClinicalTrials.gov.

Authors:  Claus Zippel; Sabine Bohnet-Joschko
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.